Drug Discovery Research, Astellas Pharma Inc., 21 Miyukigaoka, Tsukuba, Ibaraki 305-8585, Japan.
Drug Discovery Research, Astellas Pharma Inc., 21 Miyukigaoka, Tsukuba, Ibaraki 305-8585, Japan.
Bioorg Med Chem. 2020 Jul 1;28(13):115531. doi: 10.1016/j.bmc.2020.115531. Epub 2020 Apr 30.
The M muscarinic acetylcholine receptor (mAChR) is a member of the family of mAChRs, which are associated with a variety of physiological functions including the contraction of various smooth muscle tissues, stimulation of glandular secretion, and regulation of a range of cholinergic processes in the central nerve system. We report here the discovery and a comprehensive structure--activity relationships (SARs) study of novel positive allosteric modulators (PAMs) of the M mAChR through a high throughput screening (HTS) campaign. Compound 9 exhibited potent in vitro PAM activity towards the M mAChR and significant enhancement of muscle contraction in a concentration-dependent manner when applied to isolated smooth muscle strips of rat bladder. Compound 9 also showed excellent subtype selectivity over other subtypes of mAChRs including M, M, and M mAChRs, and moderate selectivity over the M mAChR, indicating that compound 9 is an M-preferring M/M dual PAM. Moreover, compound 9 displayed acceptable pharmacokinetics profiles after oral dosing to rats. These results suggest that compound 9 may be a promising chemical probe for the M mAChR for further investigation of its pharmacological function both in vitro and in vivo.
M 毒蕈碱型乙酰胆碱受体(mAChR)是 mAChR 家族的成员之一,与多种生理功能相关,包括各种平滑肌组织的收缩、腺体分泌的刺激以及中枢神经系统中一系列胆碱能过程的调节。我们在此报告了通过高通量筛选(HTS)活动发现并全面研究了新型 M 型毒蕈碱型乙酰胆碱受体的正变构调节剂(PAM)。化合物 9 在体外对 M 型毒蕈碱型乙酰胆碱受体具有很强的 PAM 活性,并且当应用于大鼠膀胱的分离平滑肌条时,以浓度依赖的方式显著增强肌肉收缩。化合物 9 对其他 mAChR 亚型(包括 M、M 和 M 型毒蕈碱型乙酰胆碱受体)也表现出优异的亚型选择性,对 M 型毒蕈碱型乙酰胆碱受体具有中等选择性,表明化合物 9 是一种 M 型优先的 M/M 双重 PAM。此外,化合物 9 在大鼠口服给药后表现出可接受的药代动力学特征。这些结果表明,化合物 9 可能是研究 M 型毒蕈碱型乙酰胆碱受体在体外和体内药理学功能的有前途的化学探针。